Lena-Christin Conradi

9PUBLICATIONS
88CO-AUTHORS
Molecular targetsPredictive and prognostic markersMechanobiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 12, 2026
Targeting PRMT5 Inhibitor-Induced Adaptation in Pancreatic Cancer with the RBM39 Degrader Indisulam.

|Mar 28, 2026
Spatially-resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma.

Alexandra Maria Schmitt, Fabio Bennet Gätje, Michelle Yi Ran Tran

|Aug 09, 2024
Integrated single-cell RNA-seq analysis reveals mitochondrial calcium signaling as a modulator of endothelial-to-mesenchymal transition.

Mathilde Lebas, Giorgia Chinigò, Evan Courmont

|Jul 15, 2024
Tumor Vessel Normalization via PFKFB3 Inhibition Alleviates Hypoxia and Increases Tumor Necrosis in Rectal Cancer upon Radiotherapy.

Marcus Edelmann, Shuang Fan, Tiago De Oliveira

|Mar 11, 2024
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition.

Tamara Isermann, Kim Lucia Schneider, Florian Wegwitz

|Nov 14, 2023
Implications of Rectal Cancer Radiotherapy on the Immune Microenvironment: Allies and Foes to Therapy Resistance and Patients' Outcome.

Dorothée Sartorius, Moritz Leander Blume, Johannes Robert Fleischer

Pageof 2

Frequent Collaborators

4 joint publications

Tiago De Oliveira

2 joint publications

Tamara Isermann

2 joint publications

Ramona Schulz-Heddergott

2 joint publications

Michael Ghadimi